EAM
CBST

Eagle Asset Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Eagle Asset Management’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-40,223
Closed -$4.05M – 669
2014
Q4 		$4.05M Sell
40,223
-685,123
-94% -$53.3M 0.02% 456
2014
Q3 		$48.1M Sell
725,346
-241,629
-25% -$15.9M 0.28% 127
2014
Q2 		$67.5M Sell
966,975
-566,315
-37% -$38.5M 0.37% 92
2014
Q1 		$112M Sell
1,533,290
-715,777
-32% -$53.4M 0.62% 31
2013
Q4 		$155M Sell
2,249,067
-490,139
-18% -$31.7M 0.87% 13
2013
Q3 		$178M Buy
2,739,206
+284,527
+12% +$17.2M 0.88% 9
2013
Q2 		$119M Buy
+2,454,679
New +$121M 0.79% 17

Eagle Asset Management's CBST Position: Q1 2015 in Review

Eagle Asset Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 40,223 shares — an estimated $4.05M sold.

Eagle Asset Management first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $178M in Q3 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Eagle Asset Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Eagle Asset Management sold 40,223 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $4.05M.
  • Eagle Asset Management first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Eagle Asset Management's CUBIST PHARMACEUTICALS INC position peaked at $178M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Eagle Asset Management's 13F filing for Q1 2015, filed 22 Apr 2015.